The cannabis sector continued its volatility this week as investors weigh current fundamentals against the sector's longer-term outlook.
The AdvisorShares Pure U.S. Cannabis ETF MSOS fell about 3.7% this week and the Global X Cannabis ETF POTX fell more than 6% this past week but rose more than 2% during Friday's session.
TheStreet's ETFFocus discussed how hot marijuana stocks have been to start the year and pointed out the performance of four cannabis ETFs in 2021.
If you're looking for the best stocks to invest in in the cannabis sector, TheStreet's Debra Borchardt shared her top stock picks in the cannabis sector for 2021 at the beginning of the year.
Here is a list of the cannabis stocks to watch and their performance from this past week by the percentage change at the close of trading on Feb. 19.
Tilray TLRY | Declined -0.5%
Tilray (TLRY) - Get Report reported a net loss of $3 million, or 2 cents per share, on revenue that rose 20.5% year-over-year to $56.6 million. A year ago, the company reported a net loss of $219.8 million, or $2.14 per share.
Analysts polled by FactSet were expecting a loss of 14 cents per share on sales of $56 million.
Hexo Corp. | Increased +8.2%
Aurora Cannabis | Decreased -2.4%
TheStreet Quant Ratings rates Aurora Cannabis Inc. as a Sell with a rating score of D-.
Aphria Inc | Increased +19.5%
Trulieve Cannabis Corp. | Flat
Trulieve is one of James "RevShark" DePorre's favorite cannabis stocks in the sector.
Village Farms | Increased +4.8%
TheStreet Quant Ratings rates Village Farms as a Hold with a rating score of C-.
GW Pharma | Flat
TheStreet Quant Ratings rates GW Pharma as a Sell with a rating score of D+.
Cronos Group | Increased +2.16%
TheStreet Quant Ratings rates Cronos Group as a Hold with a rating score of C.
Canopy Growth Corp. | Decreased -4.66%
But that wasn't enough to bring the stock into positive territory for the week.
TheStreet Quant Ratings rates Canopy Growth Corp as a Hold with a rating score of C.
NOTE: Recently, Quantitative Analysis by TheStreet Quant Ratings objectively rated these stocks according to its risk-adjusted total return prospect over a 12-month investment horizon. Not based on the news on any given day, the rating may differ from Jim Cramer's view or that of this articles' author.